Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
NanoViricides
NNVC
$38.8M
| $90K | ﹤0.01% |
78,600
+7,506
| +11% | +$9.07K |
|
|
ORKA
3502
Oruka Therapeutics
ORKA
$5.82B
| $90K | ﹤0.01% |
3,708
+400
| +12% | +$9.85K |
|
3503
DNA X Inc
SONM
$5.05M
| $89K | ﹤0.01% |
+429
| New | +$83.8K |
|
3504
Orchestra BioMed
OBIO
$238M
| $88K | ﹤0.01% |
+12,600
| New | +$191K |
|
|
TTNP
3505
DELISTED
Titan Pharmaceuticals
TTNP
| $88K | ﹤0.01% |
6,781
+10
| +0.1% | +$153 |
|
3506
Aurora
AUR
$12.6B
| $86K | ﹤0.01% |
29,400
-12,400
| -30% | -$20.8K |
|
3507
Owlet
OWLT
$149M
| $86K | ﹤0.01% |
17,964
+3,900
| +28% | +$16K |
|
3508
Xenetic Biosciences
XBIO
$5.82M
| $85K | ﹤0.01% |
25,782
+15,831
| +159% | +$59K |
|
|
CMLS
3509
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $85K | ﹤0.01% |
20,700
-32,346
| -61% | -$109K |
|
|
AAU
3510
DELISTED
Almaden Minerals Ltd
AAU
| $85K | ﹤0.01% |
658,396
-16,704
| -2% | -$2.27K |
|
|
FGNX
3511
FG Nexus Inc
FGNX
$41.6M
| $84K | ﹤0.01% |
361
-6
| -2% | -$1.62K |
|
3512
Pluri
PLUR
$16.7M
| $84K | ﹤0.01% |
13,150
+262
| +2% | +$1.86K |
|
3513
Eledon Pharmaceuticals
ELDN
$261M
| $83K | ﹤0.01% |
60,373
+28,200
| +88% | +$58.8K |
|
|
CHRN
3514
ChronoScale Holdings
CHRN
$3.2B
| $82K | ﹤0.01% |
3,840
+473
| +14% | +$10.5K |
|
3515
Toro Corp
TORO
$179M
| $82K | ﹤0.01% |
+21,600
| New | +$70.8K |
|
3516
Exicure
XCUR
$10.2M
| $82K | ﹤0.01% |
12,580
-640
| -5% | -$3.3K |
|
|
OTMO
3517
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
| $82K | ﹤0.01% |
13,613
+1,126
| +9% | +$7.16K |
|
|
WKEY
3518
WISeKey
WKEY
$70.3M
| $81K | ﹤0.01% |
18,300
-1,360
| -7% | -$7.74K |
|
3519
Jasper Therapeutics
JSPR
$21M
| $80K | ﹤0.01% |
5,810
-5,210
| -47% | -$77.4K |
|
3520
Lineage Cell Therapeutics
LCTX
$269M
| $79K | ﹤0.01% |
+55,900
| New | +$77.2K |
|
3521
MicroSectors FANG & Innovation -3x Inverse Leveraged ETN
BERZ
$19.3M
| $78K | ﹤0.01% |
+53
| New | +$124K |
|
|
ILPT
3522
Industrial Logistics Properties Trust
ILPT
$575M
| $78K | ﹤0.01% |
+23,510
| New | +$52.5K |
|
3523
Neuropace
NPCE
$439M
| $78K | ﹤0.01% |
17,300
+2,800
| +19% | +$12.7K |
|
|
AMBR
3524
Amber International Holding Ltd
AMBR
$130M
| $78K | ﹤0.01% |
55,603
-9,300
| -14% | -$24K |
|
|
SLNA
3525
DELISTED
Selina Hospitality PLC Ordinary Shares
SLNA
| $78K | ﹤0.01% |
76,416
+21,016
| +38% | +$26.2K |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.